Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.37 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | USP2 | O75604 | 2/20 | 0.36 |
| ▸ | CFTR | P13569 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21741328 | 0.91 | KMT2A (0.37) | KMT2AL3MBTL1CA2CA4CA5A | |
| SCHEMBL21973180 | 0.79 | ALDH1A1 (0.43) | KMT2AL3MBTL1ALDH1A1MEN1POLB | |
| SCHEMBL22100873 | 0.78 | GPR84 (0.33) | L3MBTL1TSHRALDH1A1 | |
| SCHEMBL22335663 | 0.77 | TSHR (0.42) | KMT2AL3MBTL1CA2CA4CA5A | |
| SCHEMBL23369444 | 0.73 | DRD1 (0.36) | KMT2AMEN1 | |
| SCHEMBL24975959 | 0.73 | KMT2A (0.39) | KMT2AL3MBTL1CA2CA4CA5A | |
| SCHEMBL19778561 | 0.69 | KMT2A (0.42) | KMT2AL3MBTL1CA2CA4CA5A | |
| SCHEMBL22229050 | 0.69 | KMT2A (0.42) | KMT2AL3MBTL1CA2CA4CA5A | |
| SCHEMBL19778904 | 0.69 | TSHR (0.44) | KMT2AL3MBTL1CA2CA4CA5A | |
| SCHEMBL8847094 | 0.69 | KMT2A (0.53) | KMT2AL3MBTL1CA2CA4CA5A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021256633-A1 | ECO-FRIENDLY HEAT-SHIELDING COMPOSITE TUNGSTEN COMPOSITION AND METHOD FOR PREPARING SAME | 황태경 | 2021-12-23 | — | — | WO | disclosed |
| US-20190227047-A1 | CONDITION DIAGNOSIS AND A LIFE-EXTENDING TREATMENT METHOD FOR AN ELECTRIC APPARATUS CONTAINING INSULATION OIL AND ITS ASSOCIATED SYSTEM | VP DIAGNOSE AS (NO) | 2019-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190227047-A1 | CONDITION DIAGNOSIS AND A LIFE-EXTENDING TREATMENT METHOD FOR AN ELECTRIC APPARATUS CONTAINING INSULATION OIL AND ITS ASSOCIATED SYSTEM | GSS, TST, SELENOI | KMT2A 3593/4885L3MBTL1 2167/4885CA2 2145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.